The agency said this review will further evaluate the risk of blood clots in women who use these products. The FDA said it is aware of two newly published studies that evaluated the risk of venous thromboembolism (VTE) in women who use birth control pills that contain drospirenone. The two recently published studies looked at whether there is a higher risk of blood clots in women taking birth cont